• 제목/요약/키워드: breast carcinoma

검색결과 588건 처리시간 0.024초

구강편평상피암종에서 stromal cell-derived factor-1의 발현 (Stromal cell-derived factor-1 (SDF-1) expression in the oral squamous cell carcinoma)

  • 김경욱;한세진;노규섭
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제36권1호
    • /
    • pp.1-6
    • /
    • 2010
  • Purpose: Chemokines are structurally related, small polypeptide signaling molecules that bind to and activate a family of transmembrane G protein-coupled receptors, the chemokine receptors. Recently, interaction between the chemokine receptor CXCR4 and its ligand, stromal cell-derived factor 1 (SDF-1 or CXCL12), has been found to play an important role in tumorigenicity, proliferation, metastasis and angiogenesis in many cancers such as lung cancer, breast cancer, melanoma, glioblastoma, pancreatic cancer and cholangiocarcinoma. Hence, the goal of this study is to identify the correlation of clinicopathological factors and the up-regulation of SDF-1 expression in oral squamous cell carcinoma. Material and methods: We studied the immunohistochemical staining of SDF-1, quantitative RT-PCR (qRT-PCR) of SDF-1 gene in 20 specimens of 20 patients with oral squamous cell carcinoma. Results: 1. In the immunohistochemical study of poor differentiated and invasive oral squamous cell carcinoma, the high level staining of SDF-1 was observed. And the correlation between immunohistochemical SDF-1 expression and tumor nodes metastases (TNM) classification of specimens was significant.($x^2$ test, P < 0.05) 2. In the SDF-1 gene qRT-PCR analysis, SDF-1 expression was more in tumor tissue than in carcinoma in situ tissue. Paired-samples analysis determined the difference of SDF-1 mRNA expression level between the cancer tissue and the carcinoma in situ tissue.(Student's t-test, P < 0.05) Conclusion: These findings suggest that up-regulation of the SDF-1 may play a role in progression and invasion of oral squamous cell carcinoma.

유방 종양 세포 조직 영상의 분류 (Classification of Breast Tumor Cell Tissue Section Images)

  • 황해길;최현주;윤혜경;남상희;최흥국
    • 융합신호처리학회논문지
    • /
    • 제2권4호
    • /
    • pp.22-30
    • /
    • 2001
  • 본 논문은 유방질환 중에서 유관(duct )에 발생하는 유방종양을 Benign, DCIS(ductal carcinoma in situ) NOS (invasive ductal carcinoma)로 분류하기 위해 3가지 분류기 (classifier) 를 생성한 후, 비교 분석하였다. 분류기 생성에서 가장 중요한 단계인 특징 추출 단계에서 세포핵의 기하학적 특징을 형태학적 특징을 추출하여 분류기를 생성하고 염색질 패턴의 내부적 변화를 나타내는 질감 특징을 추출하여 2가지 배율(100/400배)에서 2개의 분류기를 생성하였다. 400배 배율의 유방질환 영상에서 세포핵을 추출하여 핵의 형태학적 특징값인 핵의 면적, 둘레. 가로, 세로(장. 단축) 의 길이, 원형성의 비율을 구한 후 이 특징값들을 조합하여 판별분석에 의해 분류기를 생생하고, 분류 정확도를 검증하였다. 100배 배율과 400배의 배율의 유방질환 영상에서 1, 2, 3, 4 단계(level)의 wavelet 변환를 적용한 후, 분할된 서브밴드에서 GLCM(Gray Level Co-occurrence Matrix)을 이용하여 질감 특징(entropy Energy, Contrast, Homogeneity)를 추출하고, 이 특징값들을 조합하여 판변 분석에 의해 분류기를 생성한 후 분류 정확도를 검증하였다. 이 세 분류기를 비교 분석 하였을때 현민경 100배 배율의 영상을 3단계 wavelet 변환을 적용하고 질감 특징을 추출하여 생성한 분류기가 다른 두 분류기보다 유방 질환 Benign, DCIS; NOS를 분류하는데 더 나은 결과를 보였다.

  • PDF

유두 종양의 자기공명 영상소견 (MR Findings of Papillary Neoplasms of the Breast)

  • 조예슬;김성헌;강봉주;최병길
    • Investigative Magnetic Resonance Imaging
    • /
    • 제18권1호
    • /
    • pp.43-51
    • /
    • 2014
  • 목적 : 유방암을 진단 받은 환자의 자기공명영상에서 추가적으로 발견된 유두상 병변의 자기공명영상 소견과 수술적 절제 후 상향화 비율을 알아보고자 한다. 대상 및 방법 : 본원에서 유방암 진단된 환자의 수술 전 자기공명영상 1729건에서 지표 종양 외에 악성 의심 조영증강을 보인 병변 중 초음파 유도하 핵생검에서 유두 종양으로 진단된 21명의 환자의 22개 병변을 대상으로 하였다. 이 중 수술적 절제를 시행한 병변은 핵생검 결과와 절제 생검 결과를 비교하였다. 또한 이 병변들의 자기공명영상 소견을 BI-RADS MRI lexicon에 따라 후향적으로 분석하여 특징을 알아보았다. 결과 : 자기공명영상에서는 종괴 8예, 비종괴 7예, 초점 7예로 관찰되었고 초점으로 나타난 병변은 병리 조직에서 모두 (100%) 양성 병변으로 진단되었고, 역동적 조영증강 검사에서 고원형과 세척형 양상을 보였다. 양성 유두종 1예 (11.1%), 비정형요소를 가진 유두 종양 3예 (100%), 유두 종양 3예 (60%)가 수술적 절제 후 관상피내암, 침윤성 관상피암, 침윤성 소엽암 등으로 상향화되었다. 결론 : 초음파 유도하 핵생검에서 유두상 병변으로 진단된 병변들의 자기공명영상 소견은 양성과 악성을 예측하기에 특징적인 차이점을 보이지 않아 영상소견만으로 양성과 악성을 구분할 수 없으며 다수에서 수술적 절제 후 조직학적 상향화를 보여 (41.2%, 7/17) 반드시 수술적 절제를 통한 확진이 필요할 것이다.

유방암 환자에 대한 심리교육 집단개입의 효과 (A Pychoeducational Group Intervention for Women with Primary Breast Carcinoma)

  • 황숙연;이인수;박병우
    • 한국사회복지학
    • /
    • 제51권
    • /
    • pp.93-118
    • /
    • 2002
  • 우리나라에서 유방암은 여성암 중 두 번째를 차지하고 있고, 점차 증가하고 있으며 이들의 심리사회적 적응에 대한 욕구와 관심이 증대되고 있음에도 불구하고 아직 우리나라에서 유방암 환자들의 심리사회적 후유증을 감소시키기 위한 개입은 이루어지지 못하고 있다. 본 연구는 유방암 환자를 대상으로 서구에서 주로 실시되어 왔던 심리교육 집단개입이 우리나라에서도 심리적 디스트레스를 감소시키고 대처를 증진시킴으로써 심리사회적 후유증을 감소시키는데 효과가 있는지를 평가하고 이에 대한 합의를 논하는데 목적을 두었다. 유방암 수술을 받은 지 1년이 경과하지 않은 환자들 중 유방암 병기가 3기 B이상이거나 70세 이상의 환자, 거동이 불편한 환자, 지리적으로 참석이 불가능한 환자 등을 제외한 80명의 환자 중 연구에 참여를 희망하는 환자 70명을 실험집단, 대기자 통제집단 및 대기자 집단으로 무작위 할당하였다. 실험집단과 통제집단의 수는 각각 24명이었으며 최종 분석에 포함된 환자 수는 실험집단 22명, 통제집단 13명이었다. 이들에 대해 매 주 특정주제를 중심으로 8주간의 구주화된 집단개입을 실시하였으며, 프로그램은 교육과 심리적 지지를 결합한 심리교육적 전략을 사용하였다. 대상자들은 심리적 디스트레스와 대처에 대해 Beck Depression Inventory와 Ways of Coping Checklist-Revised(WCCL-R)를 실시하여 집단개입 전과 8주 후에 각각 평가하였다. 분석결과 실험집단은 통제집단에 비해 집단 개입 이후 BDI상에 나타난 우울에 대해서는 유의미하게 낮은 점수를 보였지만(p<.05). 대처에 대해서는 총점에서나 하위척도 상으로 유의미한 차이를 보이지 않았다. 연구결과와 관련하여 집단의 크기, 프로그램의 내용, 수술 후 경가 시기 등이 논의되었다. 몇 가지 한계에도 불구하고 본 연구는 우리나라에서도 단기 심리교육 집단개입이 유방암 환자들의 수술 후 심리사회적 후유증을 줄이고 삶의 질을 증진시키는 중요한 방법으로 활용될 수 있는 가능성을 보여주었다고 할 수 있다.

  • PDF

Changes in Automated Mammographic Breast Density Can Predict Pathological Response After Neoadjuvant Chemotherapy in Breast Cancer

  • Jee Hyun Ahn;Jieon Go;Suk Jun Lee;Jee Ye Kim;Hyung Seok Park;Seung Il Kim;Byeong-Woo Park;Vivian Youngjean Park;Jung Hyun Yoon;Min Jung Kim;Seho Park
    • Korean Journal of Radiology
    • /
    • 제24권5호
    • /
    • pp.384-394
    • /
    • 2023
  • Objective: Mammographic density is an independent risk factor for breast cancer that can change after neoadjuvant chemotherapy (NCT). This study aimed to evaluate percent changes in volumetric breast density (ΔVbd%) before and after NCT measured automatically and determine its value as a predictive marker of pathological response to NCT. Materials and Methods: A total of 357 patients with breast cancer treated between January 2014 and December 2016 were included. An automated volumetric breast density (Vbd) measurement method was used to calculate Vbd on mammography before and after NCT. Patients were divided into three groups according to ΔVbd%, calculated as follows: Vbd (post-NCT - pre-NCT)/pre-NCT Vbd × 100 (%). The stable, decreased, and increased groups were defined as -20% ≤ ΔVbd% ≤ 20%, ΔVbd% < -20%, and ΔVbd% > 20%, respectively. Pathological complete response (pCR) was considered to be achieved after NCT if there was no evidence of invasive carcinoma in the breast or metastatic tumors in the axillary and regional lymph nodes on surgical pathology. The association between ΔVbd% grouping and pCR was analyzed using univariable and multivariable logistic regression analyses. Results: The interval between the pre-NCT and post-NCT mammograms ranged from 79 to 250 days (median, 170 days). In the multivariable analysis, ΔVbd% grouping (odds ratio for pCR of 0.420 [95% confidence interval, 0.195-0.905; P = 0.027] for the decreased group compared with the stable group), N stage at diagnosis, histologic grade, and breast cancer subtype were significantly associated with pCR. This tendency was more evident in the luminal B-like and triple-negative subtypes. Conclusion: ΔVbd% was associated with pCR in breast cancer after NCT, with the decreased group showing a lower rate of pCR than the stable group. Automated measurement of ΔVbd% may help predict the NCT response and prognosis in breast cancer.

Triple Negative Breast Cancer in People of North East India: Critical Insights Gained at a Regional Cancer Centre

  • Sharma, Mousumi;Sharma, Jagannath Dev;Sarma, Anupam;Ahmed, Shiraj;Kataki, Amal Chandra;Saxena, Rahul;Sharma, Dilutpal
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권11호
    • /
    • pp.4507-4511
    • /
    • 2014
  • Background: Breast cancer is a heterogeneous disease comprising of distinct biological subtypes with many targeted prognostic biomarkers having therapeutic implications. However, no specific targeted therapy for triple negative breast cancer has been discovered to date and hence further research is needed. Aim: The aim and objectives of the present study were to examine the prevalence of triple negative breast cancer (TNBC) in North-East India and to compare the clinicopathological parameters in two study groups defined by immunohistochemistry (IHC) - "TNBC" and "Others". Materials and Methods: We carried out a retrospective study in a cohort of 972 patients diagnosed with invasive breast carcinoma in the Department of Pathology, Dr. B. Borooah Cancer Institute, a Regional Cancer Centre for treatment and research, Guwahati, for a period of 3 years and 10 months from January 2010 to October 2013. Based on IHC findings, patients were divided into two groups - "TNBC" and "Others". All relevant clinicopathological parameters were compared in both. TNBC were defined as those that were estrogen receptor (ER), progesterone receptor (PR), and HER2/neu negative while those positive for any of these markers were defined as "Others". Results: In this study, out of total 972 cases 31.9% (310 cases) were defined as TNBC and 662 cases (68.1%) as "Others" based on IHC markers. Compared to the "Others" category, TNBC presented at an early age (mean 40 years), were associated with high grade large tumours and high rate of node positivity, IDC NOS being the most common histological subtype in TNBC. Conclusions: TNBC accounts for a significant portion of breast cancers in this part of India and commonly present at younger age and tend to be large high grade tumours.

Somatic Mutations of the ENPP2 (Autotaxin/lysoPLD) Gene in Breast Cancer

  • Song, Jae-Hwi;Kim, Jeong-Kyu;Noh, Ji-Heon;Jung, Kwang-Hwa;Eun, Jung-Woo;Kim, Chang-Jae;Bae, Hyun-Jin;Xie, Hong-Jian;Ahn, Young-Min;Lee, Sug-Hyung;Yoo, Nam-Jin;Lee, Jung-Young;Park, Won-Sang;Nam, Suk-Woo
    • Molecular & Cellular Toxicology
    • /
    • 제3권4호
    • /
    • pp.262-266
    • /
    • 2007
  • ENPP2, a 125 kDa secreted lysophopholipase D which originally identified as a tumor-motogen, Autotaxin, enhances cellular locomotion, cell proliferation, angiogenesis and cell survival by generating the signal molecule lysophosphatic acid or sphingosine-1-phosphate. Previous studies have suggested that expression of Autotaxin is associated with invasive phenotype in advanced breast carcinomas. Thus, to determine whether genetic alterations of ENPP2 gene are involved in the development or progression of breast cancer, we analyzed its somatic mutation in 85 breast carcinomas by single-stranded conformational polymorphism and sequencing. Overall, six ENPP2 mutations were found (7.0%), comprising five missense and one nonsense mutation (s). To our knowledge, this is the first report on ENPP2 mutation in breast carcinoma, and the data indicate that ENPP2 is occasionally mutated in breast carcinomas, and suggest that ENPP2 mutation may contribute to the tumor development in some breast carcinomas.

Clinicopathologic Features and Molecular Subtypes of Breast Cancer in Young Women (Age ≤35)

  • Goksu, Sema Sezgin;Tastekin, Didem;Arslan, Deniz;Gunduz, Seyda;Tatli, Ali Murat;Unal, Dilek;Salim, Derya;Guler, Tunc;Coskun, Hasan Senol
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권16호
    • /
    • pp.6665-6668
    • /
    • 2014
  • Introduction: Breast cancer in young women is a relatively rare disease; however it tends to be more aggressive and is the leading cause of cancer death in this population. The aim of this study is to investigate the clinical and biological features of breast cancer arising in young Turkish breast cancer patients. Materials and Methods: Patients with breast cancer aged 35 or less (${\leq}35$ years) were selected for the study. In total 211 cases were included. Pathologic features; histologic subtypes, grade, lymphovascular invasion, axillary involvement, and stage were recorded for each. Results: The most common subtype was luminal B (36.5%), followed by luminal A (30.8%), triple negative (23.2%) and HER2+(9.5%) subtypes. Twelve percent of the patients had stage 4, 32.7% had stage 3, 46.4% had stage 2, and 6.2% had stage 1 disease at the time of diagnosis. Mean tumour diameter was 3.87 cm (range 0.3-13 cm). The axillary lymph nodes were positive in 74.4% of the patients, while lympho-vascular invasion was seen in 56.4%. Some 9.5% of patients had grade 1, 51.2% had grade 2, and 31.8% had grade 3 tumors. Conclusions: Young women with breast cancer in Turkey are more likely to present with luminal B subtype. Tumors in young women are more likely to present with advanced disease, to be high grade and and to have more lymphovascular invasion. Further research should focus on whether we need new treatment strategies for young patients with breast carcinoma.

Reasons for Patient's Delay in Diagnosis of Breast Carcinoma in Pakistan

  • Memon, Zahid Ali;Shaikh, Anum Nizamuddin;Rizwan, Sundus;Sardar, Maimoona Batool
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권12호
    • /
    • pp.7409-7414
    • /
    • 2013
  • Background: Delay in diagnosis of breast cancer is associated with a poorer survival and a pivotal contribution to this delayed diagnosis comes from patient delay in presenting at a clinic. Reasons involved must be evaluated in order to decrease this reducible delay. Objectives: i) To evaluate the reasons for patient delay in diagnosis of breast cancer; ii) to investigate any association with other variables. Materials and Methods: A 6 month cross sectional study (from July 2012 to Dec 2012), was carried out in Surgical and Oncology Units of Civil Hospital, Karachi. A total of 100 females diagnosed with breast cancer of any histological type were interviewed after informed consent and relevant data were collected. Due ethical clearance was obtained. Results: Mean age was $47.5{\pm}12.1$ years with a range from 25-77 years. Mean duration of delay was $5.13{\pm}4.8$ months, from shortest 1 month to longest 36 months. Duration of delay was observed to be no delay (<1 month) in 28%, short delay (1-3 months) in 30% and long delay (>3 months) in 42% of patients. Considering the symptoms as "harmless" (39%) was the most frequent reason of delay followed by "temporary" (20%) and the "use of traditional methods" (12%). Most common reason for later approaches was an increase in the size of the lump (41%). Statistically significant association (p-value <0.05) of longer patient delay was obtained with being single, being illiterate, painless breast lump as the first symptom, negative family history of breast cancer and vague attribution of the symptoms. Conclusions: Significant delay in approach to health care facility was observed in our study due to variable reasons given by women. Sufficient awareness regarding breast cancer, its symptoms and favorable effects of a timely diagnosis on prognosis must be imparted to our general population.

세침흡인 세포검사상 고위험군 유방병변으로 진단한 섬유선종의 세포학적 분석 (Cytologic Analysis of Fibroadenomas of Breast Overdiagnosed as High Risk Group in Fine Needle Aspiration Cytology)

  • 박성혜;윤길숙;최미선;강신광
    • 대한세포병리학회지
    • /
    • 제10권2호
    • /
    • pp.127-131
    • /
    • 1999
  • Among total 108 cases of biopsy-proven fibroadenomas of the breast which obtained from the files of the Asan Medical Center during one year period from October 1998 to September 1999, 23 cases cytologically diagnosed as high risk group were reviewed to retrieve the mis-loading factors. Initial cytologic diagnoses of 23 cases were proliferative breast lesion with atypia(high risk) on 21 cases(91.3%) and papillary neoplasm in 2 cases(8.7%). When we reanalysed 23 cases by Masood scoring system, they were classified as one non-proliferative breast lesion(4.3%), 16 proliferative breast lesions without atypia (69.6%), and 6 proilferative breast lesions with atypia(25.1%). None were subject to the category of carcinoma. Cytologic features loading to the overdiagnosis of high grade epithelial lesions were as follows; cellular dissociation without nuclear atypia, nuclear pleomorphism, anisonucleosis, and occasional macronucleoli without nuclear enlargement, lack of myxoid stroma, and few naked stromal cells. To avoid cytologic overdiagnosis of fibroadenoma, mild to moderate nuclear pieomorphism without nuclear enlargement and cellular dissociation without nuclear atypia should not be regarded as criteria of high risk group.

  • PDF